IRIS
DI AGOSTINO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 498
EU - Europa 127
Continente sconosciuto - Info sul continente non disponibili 16
AS - Asia 14
SA - Sud America 6
Totale 661
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 497
IT - Italia 46
SE - Svezia 38
GB - Regno Unito 19
EU - Europa 15
DE - Germania 9
NL - Olanda 9
BR - Brasile 4
IN - India 4
CN - Cina 3
CL - Cile 2
IL - Israele 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CA - Canada 1
IR - Iran 1
JP - Giappone 1
KW - Kuwait 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UA - Ucraina 1
Totale 661
Salva come PNG Salva come JPEG
Città #
Chandler 121
Lawrence 57
Princeton 57
Wilmington 35
Des Moines 23
Ashburn 22
Chicago 22
London 16
Rome 14
Hanover 8
West Jordan 8
Norwalk 6
Rende 6
Sesto Fiorentino 4
Florence 3
Pune 3
Redmond 3
Salt Lake City 3
São Paulo 3
The Dalles 3
Assago 2
Dronten 2
Haifa 2
Horia 2
Naples 2
Shanghai 2
Trescore Balneario 2
Buffalo 1
Catanzaro 1
Eden Prairie 1
Fremont 1
Grottaglie 1
Kemerovo 1
Košice 1
Kuwait City 1
Manila 1
Marshall 1
Milan 1
Modugno 1
Mountain View 1
Nashville 1
New York 1
Padova 1
Philadelphia 1
Reggio Calabria 1
San Francisco 1
Seattle 1
Tokyo 1
Toronto 1
West Palm Beach 1
Totale 454
Salva come PNG Salva come JPEG
Nome #
Li-Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment 40
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies 28
MicroRNAs in head and neck squamous cell carcinoma: A possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies 27
Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells 25
Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression 23
Arenavirus as a potential etiological agent of odontogenic tumours in humans 21
Genomic instability: The pivotal role of mutant p53 in human cancers 21
17-β-estradiol elicits genomic and non-genomic responses in mouse male germ cells 21
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation 21
Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion 20
ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence 19
Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer 18
A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer 18
HMGA1 and HMGA2 protein expression in mouse spermatogenesis 16
Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer Development 15
The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs 15
Gender, mutant p53 and PML: A growing "affaire" in tumor suppression and oncogenesis 15
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins 15
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain 15
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 14
Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation 14
Analysis of the gene expression profile of mouse male meiotic germ cells 14
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells 14
Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease 13
Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy 13
Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer 12
Mutant p53: An oncogenic transcription factor 12
A Combined atomic force microscopy imaging and docking study to investigate the complex between p53 DNA binding domain and azurin 12
The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein 12
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 12
Detection of the Lassa Virus in a Group of Odontogenic Bone Tumor Tissues 10
PML surfs into HIPPO tumor suppressor pathway 10
Mutant p53 proteins: Between loss and gain of function 9
The MAPK pathway triggers activation of Nek2 during chromosome condensation in mouse spermatocytes 9
New therapeutic strategies to treat human cancers expressing mutant p53 proteins 9
Loss of two-pore channel 2 (TPC2) expression increases the metastatic traits of melanoma cells by a mechanism involving the hippo signalling pathway and store-operated calcium entry 9
PML, YAP, and p73 Are Components of a Proapoptotic Autoregulatory Feedback Loop 9
Prolin-rich tyrosine kinase 2 (PYK2) expression and localization in mouse testis 9
The impact of mutant p53 in the non-coding RNA world 8
Interaction of mutant p53 with p73: A Surface Plasmon Resonance and Atomic Force Spectroscopy study 8
The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts 8
Long non-coding MIR205HG depletes Hsa-miR-590-3p leading to unrestrained proliferation in head and neck squamous cell carcinoma 8
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome 8
MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer 8
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function 8
The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1 8
Promyelocytic leukemia protein is required for gain of function by mutant p53 8
New molecular mechanisms and clinical impact of circrnas in human cancer 8
Targeting mutant p53 in cancer: The latest insights 7
Isolation and characterization of three polyamine oxidase genes from Zea mays 7
Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth 7
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma 7
The miR-205-5p/BRCA1/RAD17 axis promotes genomic instability in head and neck squamous cell carcinomas 6
Maize polyamine oxidase: Primary structure from protein and cDNA sequencing 6
Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop 6
Signaling through Extracellular Signal-regulated Kinase Is Required for Spermatogonial Proliferative Response to Stem Cell Factor 6
Oncogenic intra-p53 family member interactions in human cancers 6
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 6
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 6
MiR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer 6
Meiotic progression of isolated mouse spermatocytes under simulated microgravity 5
Phosphorylation of High-Mobility Group Protein A2 by Nek2 Kinase during the First Meiotic Division in Mouse Spermatocytes 5
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer 4
New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine 3
Novel Insights into the Role of the Antioxidants in Prostate Pathology 3
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease 1
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis 1
Totale 787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 54 0 1 1 3 27 4 4 0
2021/2022177 1 0 2 34 10 12 3 31 14 19 37 14
2022/2023363 122 43 15 33 13 21 7 13 30 33 22 11
2023/2024153 38 14 7 12 12 32 7 10 8 11 2 0
Totale 787